Myocardial Infarction Prophylaxis
A myocardial infarction (heart attack) occurs when blood supply to part of the heart muscle is cut off, usually by a clot in a narrowed coronary artery. Prophylaxis means reducing the chances of that event happening, or happening again, through ongoing medical management.
Medicine used to treat Myocardial Infarction Prophylaxis
Who needs long-term heart attack prevention
People at elevated risk include those with established coronary artery disease, prior heart attacks, or multiple risk factors such as high blood pressure, raised cholesterol, type 2 diabetes, and smoking history. Rates of premature coronary disease are notably high across South Asia and among South Asian communities living in Singapore, Malaysia, and the Gulf, partly due to a genetic tendency toward insulin resistance and unfavourable lipid patterns.
Beta-blockers such as metoprolol are a cornerstone after a first heart attack, reducing the heart’s workload and the risk of dangerous rhythms. Broader heart and blood pressure management, including blood pressure control and lipid-lowering, forms the wider strategy around which individual medicines sit.